Ellagic Acid

Ellagic Acid

SCHEMBL20429

O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 1.00
MAPT P10636 4/20 1.00
HPGD P15428 3/20 1.00
BLM P54132 3/20 1.00
APEX1 P27695 3/20 1.00
RECQL P46063 3/20 1.00
TDP1 Q9NUW8 3/20 1.00
POLB P06746 3/20 1.00
GAA P10253 3/20 1.00
MEN1 O00255 2/20 1.00
KMT2A Q03164 2/20 1.00
PKLR P30613 2/20 1.00
GALNT2 Q10471 2/20 1.00
CA12 O43570 2/20 1.00
CA1 P00915 2/20 1.00
CA7 P43166 2/20 1.00
CA9 Q16790 2/20 1.00
CA13 Q8N1Q1 2/20 1.00
LMNA P02545 2/20 1.00
MAPK1 P28482 2/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ellagic Acid SCHEMBL30475160 1.00 KDM4E (1.00) KDM4EMAPTHPGDBLMAPEX1
Ellagic Acid SCHEMBL29439360 1.00 KDM4E (1.00) KDM4EMAPTHPGDBLMAPEX1
Ellagic Acid SCHEMBL1645767 1.00 KDM4E (1.00) KDM4EMAPTHPGDBLMAPEX1
Ellagic Acid SCHEMBL2639621 0.98 KDM4E (0.96) KDM4EMAPTHPGDBLMAPEX1
Ellagic Acid SCHEMBL21590140 0.98 KDM4E (0.96) KDM4EMAPTHPGDBLMAPEX1
Ellagic Acid SCHEMBL8686551 0.98 KDM4E (0.96) KDM4EMAPTHPGDBLMAPEX1
Ellagic Acid SCHEMBL177722 0.98 KDM4E (0.96) KDM4EMAPTHPGDBLMAPEX1
Ellagic Acid SCHEMBL8686557 0.98 KDM4E (0.96) KDM4EMAPTHPGDBLMAPEX1
Ellagic Acid SCHEMBL8686700 0.98 KDM4E (0.96) KDM4EMAPTHPGDBLMAPEX1
Ellagic Acid SCHEMBL9146254 0.98 KDM4E (0.96) KDM4EMAPTHPGDBLMAPEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 29076 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-5156084-A None JP claimed
EP-4748438-A2 ENTERICALLY DELIVERED BITTER OLIGOPEPTIDES FOR THE TREATMENT FOR TYPE 2 DIABETES Cedars-Sinai Medical Center (US) 2026-05-27 EP claimed
CN-118266586-B Composite plant product and preparation method and application thereof COFCO NUTRITION AND HEALTH RESEARCH INSTITUTE Co.,Ltd. (CN) 2026-05-26 CN claimed
CN-122080694-A Rosmarinic acid composite coating, preparation method thereof and application thereof in postharvest preservation of blueberry fruits 2026-05-26 CN claimed
CN-122084607-A Method for monitoring coagulation activity and corresponding system 2026-05-26 CN claimed
CN-122075567-A A composition containing herba Silybi Mariani extract and Akk bacteria 2026-05-26 CN claimed
US-20260139182-A1 FILTER CAKE REMOVAL COMPOSITIONS AND RELATED WELLBORE METHODS HALLIBURTON ENERGY SERVICES INC (US) 2026-05-21 US claimed
WO-2026107510-A1 HOT-MELT ADHESIVE COMPOSITION AND METHOD OF APPLICATION BIOBOND ADHESIVES, INC. (US) 2026-05-21 WO claimed
US-20260137751-A1 ENTERICALLY DELIVERED BITTER OLIGOPEPTIDES FOR THE TREATMENT FOR TYPE 2 DIABETES CEDARS-SINAI MEDICAL CENTER (US) 2026-05-21 US claimed
EP-4743181-A1 POLYPHENOL-RICH DAMASK ROSE EXTRACT DERIVED FROM A HYDRODISTILLATION BYPRODUCT AND ITS USES AS A FOOD SUPPLEMENT Robertet S.A. (FR) 2026-05-20 EP claimed
US-4885244-A CONTACTING MICROORGANISM WITH SACCHARIDE IN POLYHYDRIC AROMATIC COMPOUND CONTAINING MEDIUM; HIGH MOLECULAR WEIGHT MITSUBISHI RAYON CO., LTD. (JP) 1989-12-05 US claimed
EP-0190766-B1 DETERMINATION OF PROKALLIKREIN Roche Diagnostics GmbH (DE) 1989-05-31 EP claimed
EP-0294808-A1 Agent for external application and use thereof LION CORPORATION (JP) 1988-12-14 EP claimed
EP-0262541-A1 Protective compositions with iron oxide conversion action Muzzi, Maria Grazia (IT) 1988-04-06 EP claimed
US-4732860-A COLORIMETRIC ANALYSIS BOEHRINGER MANNHEIM GMBH (DE) 1988-03-22 US claimed
US-4598043-A Method for quantitatively assaying blood coagulation factor XII in human plasma PENTAPHARM AG (CH) 1986-07-01 US claimed
EP-0078764-B1 PROCESS FOR THE QUANTITATIVE DETERMINATION OF THE BLOOD CLOTTING FACTOR XII IN HUMAN PLASMA Pentapharm A.G. (CH) 1986-01-02 EP claimed
EP-0020895-B1 A PARTIAL THROMBOPLASTINE BEHRINGWERKE Aktiengesellschaft (DE) 1984-05-23 EP claimed
US-4293349-A GLUCOSIDES OF PYROGALLIC OR ELLAGIC ACID, PHOSPHORIC ACID, ZINC OR MANGANESE PHOSPHATE AND NITRATE PARKER ITALIANA S.A.S. (IT) 1981-10-06 US claimed
US-4179455-A PARTIAL HYDROGENATION, HYDRAULIC PRESSURE CADBURY INDIA LIMITED (IN) 1979-12-18 US claimed